Efficacy and safety of Aspirin use for primary prevention of cardiovascular disease in diabetic patients
Phase 1
Active, not recruiting
- Conditions
- Diabetic patient Aspirin Primary prevention Cardiovascular disease
- Registration Number
- TCTR20220804004
- Lead Sponsor
- Pakchong Nana hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 560
Inclusion Criteria
Diabetic patient who diagnosis since 2010 at Pakchong Nana hospital
Exclusion Criteria
Diabetic patient who had Aspirin drug allergy and uncompleted all data to collect
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular disease 10 years Retrospective data collection
- Secondary Outcome Measures
Name Time Method Major gastrointestinal bleeding and Hemorrhagic stroke 10 years Retrospective data collection